C61
Conditions
Interventions
Group 1: Evaluation of patient data regarding the median PSA, the T stage, Gleason score before radical prostatectomy and after surgical resection.
Evaluation of the patient data on the median age at
Sponsors
Universitätsklinikum Freiburg,
Klinik für Strahlenheilkunde
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Patients with a history of prostate carcinoma Prostatavesikolektomie because of a biochemical (PSA) recurrence (definition of PSA recurrence: three consecutive rising PSA values ??above the nadir,> 3 months after surgery) - Have received no anti-hormonal therapy prior to radiotherapy - MRI scan prior to initiation of radiotherapy - PSA follow-up of at least 1 year after the end of radiotherapy
Exclusion criteria
Exclusion criteria: Clinical and imaging suspicion of lymph node metastases or distant metastases before initiation of radiation therapy to the pelvis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity, specificity and accuracy of DCE-MRI without endorectal coil in the detection of local recurrent PC at very low PSA levels. | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation of tumor size to pre-RT PSA-level. | — |
Countries
Germany
Contacts
Public ContactHans Christian Rischke
Universitätsklinikum Freiburg, Klinik für Strahlenheilkunde
Outcome results
None listed